These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 11473064)
1. Serum type IV collagen in diabetic patients at risk for nephropathy. Cohen MP; Shearman CW; Lautenslager GT Diabetes Care; 2001 Aug; 24(8):1324-7. PubMed ID: 11473064 [TBL] [Abstract][Full Text] [Related]
2. Increased collagen IV excretion in diabetes. A marker of compromised filtration function. Cohen MP; Lautenslager GT; Shearman CW Diabetes Care; 2001 May; 24(5):914-8. PubMed ID: 11347754 [TBL] [Abstract][Full Text] [Related]
3. Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria. Nakamura T; Ushiyama C; Suzuki S; Shimada N; Sekizuka K; Ebihara L; Koide H Diabet Med; 2001 Apr; 18(4):308-13. PubMed ID: 11437862 [TBL] [Abstract][Full Text] [Related]
4. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Ellis D; Forrest KY; Erbey J; Orchard TJ Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367 [TBL] [Abstract][Full Text] [Related]
5. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy. Banu N; Hara H; Egusa G; Yamakido M Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578 [TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage. Banu N; Hara H; Okamura M; Egusa G; Yamakido M Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760 [TBL] [Abstract][Full Text] [Related]
7. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes. Hayashi Y; Makino H; Ota Z Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709 [TBL] [Abstract][Full Text] [Related]
8. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Gilbert RE; Akdeniz A; Weitz S; Usinger WR; Molineaux C; Jones SE; Langham RG; Jerums G Diabetes Care; 2003 Sep; 26(9):2632-6. PubMed ID: 12941731 [TBL] [Abstract][Full Text] [Related]
9. Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy. Iijima T; Suzuki S; Sekizuka K; Hishiki T; Yagame M; Jinde K; Saotome N; Suzuki D; Sakai H; Tomino Y J Clin Lab Anal; 1998; 12(6):378-82. PubMed ID: 9850190 [TBL] [Abstract][Full Text] [Related]
10. Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy. Tomino Y; Suzuki S; Azushima C; Shou I; Iijima T; Yagame M; Wang LN; Chen HC; Lai KN; Tan SY; Kim MJ J Clin Lab Anal; 2001; 15(4):188-92. PubMed ID: 11436201 [TBL] [Abstract][Full Text] [Related]
11. Urinary type IV collagen levels in diabetes mellitus. Sthaneshwar P; Chan SP Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725 [TBL] [Abstract][Full Text] [Related]
12. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice. Cohen MP; Lautenslager GT; Shearman CW Metabolism; 2001 Dec; 50(12):1435-40. PubMed ID: 11735089 [TBL] [Abstract][Full Text] [Related]
13. Difference of serum levels of type IV collagen 7S between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro- or macroalbuminuria. Inomata S; Itoh M; Sato T Nephron; 1996; 73(4):601-5. PubMed ID: 8856258 [TBL] [Abstract][Full Text] [Related]
14. Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay. Yagame M; Suzuki D; Jinde K; Saotome N; Sato H; Noguchi M; Sakai H; Kuramoto T; Sekizuka K; Iijima T; Suzuki S; Tomino Y J Clin Lab Anal; 1997; 11(2):110-6. PubMed ID: 9058245 [TBL] [Abstract][Full Text] [Related]
15. Serum or urinary concentration of type IV collagen in diabetics. Watanabe T; Negishi K; Katayama S; Ishii J; Kawazu S J Diabet Complications; 1991; 5(2-3):191-2. PubMed ID: 1770043 [TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix proteins as early markers in diabetic nephropathy. Jäckle-Meyer I; Szukics B; Neubauer K; Metze V; Petzoldt R; Stolte H Eur J Clin Chem Clin Biochem; 1995 Apr; 33(4):211-9. PubMed ID: 7626693 [TBL] [Abstract][Full Text] [Related]
17. Practical aspects of measuring microalbuminuria in diabetic patients. Jermendy G; Farkas K; Nádas J; Daróczy A; Péterfai E Diabetes Nutr Metab; 2001 Aug; 14(4):195-200. PubMed ID: 11716288 [TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of intact type IV collagen in diabetics. Matsumoto E; Matsumoto G; Bessho H; Kikuoka H; Nanjo K J Diabet Complications; 1991; 5(2-3):189-90. PubMed ID: 1770042 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum total renin is insensitive in detecting incipient diabetic nephropathy. Matinlauri IH; Rönnemaa T; Koskinen PJ; Aalto MA; Vukari JS; Irjala KM Diabetes Care; 1995 Oct; 18(10):1357-61. PubMed ID: 8721937 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy. Nishimura M; Sasaki T; Ohishi A; Oishi M; Kono S; Totani Y; Kato Y; Noto Y; Misaki S; Higashi K; Shimada F; Wakasugi H; Inoue K; Hoshiyama Y; Yamada K Clin Nephrol; 2001 Aug; 56(2):96-103. PubMed ID: 11522101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]